Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuko Abiko

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Diabetology International|October 22, 2020
The work style and living condition survey of diabetologists and the expectations for the Japan Diabetes Society: results of questionnaires about the current state and the future prospect of their carrier in 2017Keiko Naruse, Atsuko Abiko, Hitomi Nakayama, et al.
Ebiomedicine|October 17, 2018
Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8Yumi Takiyama, Toshihiro Sera, Masanori Nakamura, et al.
Journal of Diabetes Investigation|March 24, 2025
Analysis of the Japanese gestational diabetes mellitus diagnostic strategy during the coronavirus disease 2019 pandemic using DREAMBee study dataYoshifumi Kasuga, Kei Miyakoshi, Maki Yokoyama, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)Kohjiro Ueki, Yukio Tanizawa, Jiro Nakamura, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Diabetology International|October 22, 2020
The work style and living condition survey of diabetologists and the expectations for the Japan Diabetes Society: results of questionnaires about the current state and the future prospect of their carrier in 2017Keiko Naruse, Atsuko Abiko, Hitomi Nakayama, et al.
Ebiomedicine|October 17, 2018
Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8Yumi Takiyama, Toshihiro Sera, Masanori Nakamura, et al.
Journal of Diabetes Investigation|March 24, 2025
Analysis of the Japanese gestational diabetes mellitus diagnostic strategy during the coronavirus disease 2019 pandemic using DREAMBee study dataYoshifumi Kasuga, Kei Miyakoshi, Maki Yokoyama, et al.
BMJ Open Diabetes Research & Care|January 14, 2021
Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)Kohjiro Ueki, Yukio Tanizawa, Jiro Nakamura, et al.
Pageof 3